VRTX · Vertex Pharmaceuticals Inc · Documents
$523.93
-11.24 (-2.10%)
At close · Oct 23
Return incl. dividend (before tax)
Market Cap
$132.80B
Shares
253.46M
Volume · Oct 23
833.46K
Avg daily vol (3M)
1.18M
The company's filings as submitted to the SEC's EDGAR system — 10-K, 10-Q, 8-K, proxy statements and more — listed most recent first.
| Type | AI summary | Filing Date | Period | Open |
|---|---|---|---|---|
| 8-K | — | 2024-06-27 | — | |
| 8-K | — | 2024-05-20 | — | |
| SC TO-T/A | — | 2024-05-20 | — | |
| 8-K | — | 2024-05-15 | — | |
| SC TO-T/A | — | 2024-05-10 | — | |
| SC TO-T/A | — | 2024-05-08 | — | |
| 10-Q | — | 2024-05-07 | 2024-03-31 | |
| 8-K | — | 2024-05-06 | — | |
| SC TO-T | — | 2024-04-22 | — | |
| SC TO-C | — | 2024-04-11 | — | |
| 8-K | — | 2024-04-11 | 2024-04-10 | |
| SC TO-C | — | 2024-04-11 | — | |
| SC TO-C | — | 2024-04-10 | — | |
| DEFA14A | — | 2024-04-04 | — | |
| ARS | — | 2024-04-04 | 2023-12-31 | |
| DEF 14A | — | 2024-04-04 | 2023-05-15 | |
| 10-K | — | 2024-02-15 | 2023-12-31 | |
| 8-K | — | 2024-02-05 | — | |
| 8-K | — | 2023-12-08 | — | |
| 8-K | — | 2023-12-05 | — | |
| 10-Q | — | 2023-11-07 | 2023-09-30 | |
| 8-K | — | 2023-11-06 | — | |
| 8-K | — | 2023-10-05 | 2023-10-03 | |
| 10-Q | — | 2023-08-02 | 2023-06-30 | |
| 8-K | — | 2023-08-01 | — | |
| 8-K | — | 2023-05-18 | 2023-05-17 | |
| 10-Q | — | 2023-05-02 | 2023-03-31 | |
| 8-K | — | 2023-05-01 | — | |
| ARS | — | 2023-04-06 | 2022-12-31 | |
| DEFA14A | — | 2023-04-06 | — | |
| DEF 14A | — | 2023-04-06 | — | |
| 10-K | — | 2023-02-10 | 2022-12-31 | |
| 8-K | — | 2023-02-07 | — | |
| 10-Q | — | 2022-10-28 | 2022-09-30 | |
| 8-K | — | 2022-10-27 | — | |
| 10-Q | — | 2022-08-05 | 2022-06-30 | |
| 8-K | — | 2022-08-04 | — | |
| 8-K | — | 2022-07-11 | 2022-07-09 | |
| 8-K | — | 2022-07-05 | 2022-07-01 | |
| 8-K | — | 2022-05-23 | — | |
| 8-K | — | 2022-05-18 | — | |
| 10-Q | — | 2022-05-06 | 2022-03-31 | |
| 8-K | — | 2022-05-05 | — | |
| DEFA14A | — | 2022-04-07 | — | |
| DEF 14A | — | 2022-04-07 | 2022-05-18 | |
| 10-K | — | 2022-02-09 | 2021-12-31 | |
| S-3ASR | — | 2022-02-09 | — | |
| 8-K | — | 2022-01-26 | — | |
| 10-Q | — | 2021-11-03 | 2021-09-30 | |
| 8-K | — | 2021-11-02 | — |
Showing 51–100 of 126 filings
Key facts
CIK
875320
CUSIP
92532F100
13F (30d)
508 filings
485 filers
Visit website
Investor relations